At the end of the latest market close, Agenus Inc. (AGEN) was valued at $5.14. In that particular session, Stock kicked-off at the price of $5.16 while reaching the peak value of $5.18 and lowest value recorded on the day was $4.70. The stock current value is $4.71.
Recently in News on February 9, 2021, Andy Hurley Named Agenus Chief Commercial Officer. Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced the appointment of Andy Hurley as its Chief Commercial Officer. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Agenus Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.95 on 02/04/21, with the lowest value was $3.12 for the same time period, recorded on 01/04/21.
Agenus Inc. (AGEN) full year performance was 22.66%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Agenus Inc. shares are logging -20.84% during the 52-week period from high price, and 158.79% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.82 and $5.95.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3695515 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Agenus Inc. (AGEN) recorded performance in the market was 48.11%, having the revenues showcasing 13.49% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 899.09M, as it employees total of 328 workers.
The Analysts eye on Agenus Inc. (AGEN)
During the last month, 2 analysts gave the Agenus Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.84, with a change in the price was noted -0.47. In a similar fashion, Agenus Inc. posted a movement of -9.07% for the period of last 100 days, recording 2,455,487 in trading volumes.
Technical rundown of Agenus Inc. (AGEN)
Raw Stochastic average of Agenus Inc. in the period of last 50 days is set at 56.64%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 55.23%. In the last 20 days, the company’s Stochastic %K was 66.92% and its Stochastic %D was recorded 71.45%.
Considering, the past performance of Agenus Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 48.11%. Additionally, trading for the stock in the period of the last six months notably improved by 32.30%, alongside a boost of 22.66% for the period of the last 12 months. The shares increased approximately by -9.42% in the 7-day charts and went down by 45.37% in the period of the last 30 days. Common stock shares were driven by 13.49% during last recorded quarter.